Position in GMAB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$346,793,257
-$97,295,372 QoQ
Shares Held
12,925,578
-10.4% QoQ
Ownership
2.11%
of shares outstanding
% of Portfolio
1.46%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Orbis Allan Gray Ltd holds $2,509,849,465 across 7 Biotechnology names. GMAB ranks #3 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,472,480 | $796,608,330 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,334,825 | $441,653,547 | |
| 3 | GMAB |
Genmab A/S
This page
|
12,925,578 | $346,793,257 | |
| 4 | INSM |
INSMED Inc
|
1,872,824 | $306,244,179 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
6,106,011 | $290,462,942 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
4,179,983 | $205,487,963 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
6,762,231 | $122,599,247 |
All Filings in GMAB
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $346,793,257 | 12,925,578 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $444,088,629 | 14,418,462 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $339,762,443 | 11,078,006 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $163,635,463 | 7,920,400 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $111,816,308 | 5,710,741 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $58,760,778 | 2,815,562 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $40,880,212 | 1,676,793 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||